CrossrefInfokarte
Real–world Experience with JAK Inhibitors and Dupilumab in Dystrophic Epidermolysis Bullosa: A Case Report and Literature Review
Acta Dermato-Venereologica · 2025-05-27 · 105 · adv43588
DOI: 10.2340/actadv.v105.43588 ↗Abstract
Kein Abstract verfügbar.
EUVIMED